论文部分内容阅读
奥马佐单抗为抗免疫球蛋白E(IgE)的重组人源化(嵌合)单克隆抗体。用于治疗成人和青少年的中重度持续性哮喘。FDA最近收到奥马佐单抗引致严重危及生命过敏反应的新报告。奥马佐单抗引致过敏反应通常是在用药后2h内,但最新报
Omazumab is a recombinant humanized (chimeric) monoclonal antibody against immunoglobulin E (IgE). For the treatment of moderate and severe persistent asthma in adults and adolescents. The FDA recently received a new report that oxamazumab causes a serious life-threatening allergic reaction. Alzheimer’s allergic reactions are usually within 2h after treatment, but the latest reported